Assignee
ABBVIE BIOTECHNOLOGY LTD
BM·66 granted patents·61 pending applications·1,328 citations·filing 2013–2023
Top patents by PatentIndex Score
127 records- 0199US9114166B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 25, 2015·67 cites·30 claims
- 0299US8916157B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 23, 2014·91 cites·30 claims
- 0398US9738714B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Aug 22, 2017·22 cites·30 claims
- 0498US9272041B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·30 cites·30 claims
- 0598US8940305B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jan 27, 2015·27 cites·30 claims
- 0698US8916153B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Dec 23, 2014·48 cites·14 claims
- 0798US8916158B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 23, 2014·31 cites·30 claims
- 0898US8911741B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 16, 2014·26 cites·30 claims
- 0998US8883156B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Nov 11, 2014·46 cites·19 claims
- 1098US8802101B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Aug 12, 2014·35 cites·29 claims
- 1198US8795670B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Aug 5, 2014·27 cites·29 claims
- 1297US9327032B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted May 3, 2016·17 cites·30 claims
- 1397US9328165B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted May 3, 2016·20 cites·30 claims
- 1497US9302011B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Apr 5, 2016·17 cites·30 claims
- 1597US9295725B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 29, 2016·17 cites·30 claims
- 1697US9289497B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 22, 2016·17 cites·30 claims
- 1797US9273132B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·19 cites·26 claims
- 1897US9272042B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 1, 2016·17 cites·30 claims
- 1997US9220781B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Dec 29, 2015·19 cites·30 claims
- 2097US9102723B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 11, 2015·31 cites·28 claims
- 2197US9085619B2Anti-TNF antibody formulationsABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jul 21, 2015·83 cites·30 claims
- 2297US8906372B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Dec 9, 2014·45 cites·19 claims
- 2397US8895009B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Nov 25, 2014·46 cites·13 claims
- 2497US8802102B2Formulation of human antibodies for treating TNF-α associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 12, 2014·26 cites·29 claims
- 2596US9750808B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Sep 5, 2017·10 cites·30 claims
- 2696US9096666B2Purified antibody compositionABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 4, 2015·23 cites·30 claims
- 2795US9950066B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Apr 24, 2018·8 cites·20 claims
- 2895US9732152B2Formulation of human antibodies for treating TNF-alpha associated disordersABBVIE BIOTECHNOLOGY LTD·Filed 2017·Granted Aug 15, 2017·8 cites·30 claims
- 2995US9339610B2Removal of needle shield from syringes and automatic injection devicesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted May 17, 2016·56 cites·25 claims
- 3094US9284370B1Methods for treating juvenile idiopathic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Mar 15, 2016·11 cites·38 claims
- 3194US9090689B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 28, 2015·13 cites·21 claims
- 3294US8906373B2Use of TNF-alpha inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 9, 2014·20 cites·9 claims
- 3394US8808700B1Use of TNF alpha inhibitor for treatment of erosive polyarthritisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Aug 19, 2014·19 cites·30 claims
- 3493US9669093B2Methods for treating juvenile idiopathic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Jun 6, 2017·9 cites·31 claims
- 3593US9085620B1Use of TNFα inhibitor for treatment of psoriatic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 21, 2015·12 cites·30 claims
- 3693US9067992B2Use of TNFα inhibitor for treatment of psoriatic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jun 30, 2015·14 cites·9 claims
- 3793US8986693B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Mar 24, 2015·14 cites·8 claims
- 3893US8961974B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·28 claims
- 3993US8961973B2Multiple-variable dose regimen for treating TNFα-related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Feb 24, 2015·12 cites·30 claims
- 4093USD694879SAutomatic injection deviceABBVIE BIOTECHNOLOGY LTD·Filed 2013·Granted Dec 3, 2013·61 cites·1 claims
- 4192US10022503B2Removal of needle shield from syringes and automatic injection devicesABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Jul 17, 2018·11 cites·30 claims
- 4292US9187559B2Multiple-variable dose regimen for treating idiopathic inflammatory bowel diseaseABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 17, 2015·8 cites·30 claims
- 4392US9017680B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Apr 28, 2015·10 cites·4 claims
- 4491USD804806SMedication containerABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Dec 12, 2017·53 cites·1 claims
- 4591US9821117B2Wearable automatic injection device for controlled delivery of therapeutic agentsABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 21, 2017·13 cites·40 claims
- 4691US9486584B2Automatic injection deviceABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Nov 8, 2016·8 cites·28 claims
- 4791US9334320B2Methods of treating moderate to severe hidradenitis suppurativa with anti-TNFalpha antibodyABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted May 10, 2016·23 cites·34 claims
- 4891US9073987B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jul 7, 2015·9 cites·2 claims
- 4990US9546212B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Jan 17, 2017·5 cites·24 claims
- 5090US9512216B2Use of TNFα inhibitorABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Dec 6, 2016·5 cites·16 claims
Showing the top 50 of 127 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ABBVIE BIOTECHNOLOGY LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →